^
Association details:
| Biomarker: | PTPRC expression |
|---|---|
| Cancer: | Multiple Myeloma |
| Drug: | Darzalex (daratumumab) (CD38 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
INTEGRATIVE APPROACH TO FIND PREDICTIVE MARKERS OF RESPONSE TO DARATUMUMAB IN MULTIPLE MYELOMA
Published date:
05/12/2021
Excerpt:
We retrospectively included 97 multiple myeloma patients treated with Dara...Similarly, expression of CD27 and CD45 were significantly associated with poor response to Dara.
